Skip to main content
. Author manuscript; available in PMC: 2017 Dec 19.
Published in final edited form as: J Neurooncol. 2012 Jul 26;110(1):111–118. doi: 10.1007/s11060-012-0943-z

Table 1.

Demographics and treatment duration (n = 30)

Variable AA (%)
(n = 14)		 GB (%)
(n = 16)		 Total
(n = 30)
Sex, n (%)
  Women 2 (14.3) 6 (37.5) 8 (26.7)
  Men 12 (85.7) 10 (62.5) 22 (73.3)
Race, n (%)
  Asian 0 (0.0) 1 (6.3) 1 (3.3)
  African American 2 (14.3) 0 (0.0) 2 (6.7)
  Unknown 0 (0.0) 1 (6.3) 1 (3.3)
  White 12 (85.7) 14 (87.5) 26 (86.7)
Age, years
  Mean (SD) 46.9 (10.7) 57.8 (10.0) 52.7 (11.6)
  Median (range) 48.5 (30.0–64.0) 57.5 (44.0–77.0) 52.0 (30.0–77.0)
Duration of treatment, months
  Mean (SD) 3.1 (3.0) 2.7 (3.2) 2.9 (3.1)
  Median (range) 2.7 (0.6–12.3) 1.4 (0.5–13.6) 1.4 (0.5–13.6)